Verastem Secures $16,000,000 Series A Round

  • Feed Type
  • Date
    11/16/2010
  • Company Name
    Verastem
  • Mailing Address
    800 Boylston St. Boston, MA 02199
  • Company Description
    Verastem, Inc. is a private biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells.
  • Website
    http://www.Verastem.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $16,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Longwood Founders Fund
  • Venture Investor
    Longwood Founders Fund
  • Venture Investor
    Bessemer Venture Partners
  • Venture Investor
    MPM Capital
  • Venture Investor
    Cardinal Partners